What is a stock summary page? Click here for an overview.
Business Description
Sotera Health Co
NAICS : 541380
SIC : 8071
ISIN : US83601L1026
Share Class Description:
SHC: Ordinary SharesDescription
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.13 | |||||
| Debt-to-Equity | 5.81 | |||||
| Debt-to-EBITDA | 5.32 | |||||
| Interest Coverage | 1.81 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.27 | |||||
| Beneish M-Score | -2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5 | |||||
| 3-Year EBITDA Growth Rate | 2.6 | |||||
| 3-Year EPS without NRI Growth Rate | 14.8 | |||||
| 3-Year FCF Growth Rate | -37.3 | |||||
| 3-Year Book Growth Rate | -11.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 10.51 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.03 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.11 | |||||
| 9-Day RSI | 53.03 | |||||
| 14-Day RSI | 48.12 | |||||
| 3-1 Month Momentum % | -0.63 | |||||
| 6-1 Month Momentum % | -19.99 | |||||
| 12-1 Month Momentum % | 19.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.75 | |||||
| Quick Ratio | 2.5 | |||||
| Cash Ratio | 1.45 | |||||
| Days Inventory | 38.15 | |||||
| Days Sales Outstanding | 43.31 | |||||
| Days Payable | 47.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -0.6 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.73 | |||||
| Operating Margin % | 27.05 | |||||
| Net Margin % | 4.04 | |||||
| FCF Margin % | 4.1 | |||||
| ROE % | 10.23 | |||||
| ROA % | 1.44 | |||||
| ROIC % | 4.3 | |||||
| 3-Year ROIIC % | -52.62 | |||||
| ROC (Joel Greenblatt) % | 26.06 | |||||
| ROCE % | 9.59 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 80.43 | |||||
| Forward PE Ratio | 16.31 | |||||
| PE Ratio without NRI | 17.24 | |||||
| Price-to-Owner-Earnings | 54.99 | |||||
| PS Ratio | 3.08 | |||||
| PB Ratio | 8.44 | |||||
| Price-to-Free-Cash-Flow | 76.76 | |||||
| Price-to-Operating-Cash-Flow | 15.31 | |||||
| EV-to-EBIT | 19.88 | |||||
| EV-to-Forward-EBIT | 11.98 | |||||
| EV-to-EBITDA | 12.52 | |||||
| EV-to-Forward-EBITDA | 10.5 | |||||
| EV-to-Revenue | 5.03 | |||||
| EV-to-Forward-Revenue | 4.9 | |||||
| EV-to-FCF | 121.23 | |||||
| Price-to-GF-Value | 0.75 | |||||
| Earnings Yield (Greenblatt) % | 5.03 | |||||
| FCF Yield % | 1.32 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SHC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sotera Health Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,100.441 | ||
| EPS (TTM) ($) | 0.15 | ||
| Beta | 2.29 | ||
| 3-Year Sharpe Ratio | 0.09 | ||
| 3-Year Sortino Ratio | 0.16 | ||
| Volatility % | 38.24 | ||
| 14-Day RSI | 48.12 | ||
| 14-Day ATR ($) | 0.442383 | ||
| 20-Day SMA ($) | 12.0475 | ||
| 12-1 Month Momentum % | 19.16 | ||
| 52-Week Range ($) | 10.71 - 17.08 | ||
| Shares Outstanding (Mil) | 283.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sotera Health Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sotera Health Co Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sotera Health Co Frequently Asked Questions
What is Sotera Health Co(SHC)'s stock price today?
The current price of SHC is $12.07. The 52 week high of SHC is $17.08 and 52 week low is $10.71.
When is next earnings date of Sotera Health Co(SHC)?
The next earnings date of Sotera Health Co(SHC) is 2025-05-02 Est..
Does Sotera Health Co(SHC) pay dividends? If so, how much?
Sotera Health Co(SHC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers